Literature DB >> 23625413

Camphor modulates TRPV3 cation channels activity by interacting with critical pore-region cysteine residues.

Muhammad Azhar Sherkheli1, Angela K Vogt-Eisele, Kirsten Weber, Hanns Hatt.   

Abstract

TRPV3 ion channels mediate thermo-transduction, nociception, inflammation and dermatitis in mammals. TRPV1-4 proteins have been shown to have conserved cysteine-residues in the pore-forming regions. These residues participate in channel activation via S-nitrosylation of channel proteins. Camphor is a commonly used ligand for TRPV3 channels. Thus the knowledge about the potential binding/interacting site(s) for camphor will help to design effective and potent analgesic compounds. In an overlap-extension PCR method, following primer-pairs were used to mutate conserved cysteine-residues in the pore-region of TRPV3 channels; GATTGAGAATcCTCCAAGGACAAAAAGGAC, TRPV3-C612S-Fw and GTCCTTGGAGgACTTCTCAATCAGTCAGTGAGG, TRPV3-C612S-Rv primers pair. And for TRPV3-C619S: GGACTCcAGTTCCTATGGCCAGC, TRPV3-C619S-Fw and GCTGGCCATAgGAACTGGAGTCC, TRPV3-C619S-Rv respectively. All cDNA constructs were confirmed by DNA-sequencing and used to make cRNAs. Oocytes expressing mTRPV3-C619S and mTRPV3-C612S mutant channels were challenged with 2-APB (1 mM), camphor (10 mM) and dihydrocarveol (10 mM) either at -40 mV or +40 mV holding potentials in voltage-clamp experiments. Responses of both mutants to 2-APB were similar to wild-type mTRPV3. Interestingly, responses to camphor were totally lost in mTRPV3-C619S mutant, while responses to dihydrocarveol remained intact. In contrast mTRPV3-C612S displayed slightly altered (16±2 % reduction) phenotype with respect to camphor sensitivity. It is concluded that pore-region cysteines play critical role in camphor sensitivity of TRPV3 ion channels.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23625413

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  12 in total

Review 1.  TRPs and pain.

Authors:  Yi Dai
Journal:  Semin Immunopathol       Date:  2015-09-15       Impact factor: 9.623

Review 2.  TRPV3: time to decipher a poorly understood family member!

Authors:  Bernd Nilius; Tamás Bíró; Grzegorz Owsianik
Journal:  J Physiol       Date:  2013-07-08       Impact factor: 5.182

3.  COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels.

Authors:  Stefan Spyra; Anne Meisner; Michael Schaefer; Kerstin Hill
Journal:  Br J Pharmacol       Date:  2017-06-29       Impact factor: 8.739

4.  The structure of lipid nanodisc-reconstituted TRPV3 reveals the gating mechanism.

Authors:  Hiroto Shimada; Tsukasa Kusakizako; T H Dung Nguyen; Tomohiro Nishizawa; Tomoya Hino; Makoto Tominaga; Osamu Nureki
Journal:  Nat Struct Mol Biol       Date:  2020-06-22       Impact factor: 15.369

5.  Different ligands of the TRPV3 cation channel cause distinct conformational changes as revealed by intrinsic tryptophan fluorescence quenching.

Authors:  Bert Billen; Marijke Brams; Sarah Debaveye; Alina Remeeva; Yeranddy A Alpizar; Etienne Waelkens; Mohamed Kreir; Andrea Brüggemann; Karel Talavera; Bernd Nilius; Thomas Voets; Chris Ulens
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

6.  No Camphor Toxicity in Cambodian Infants.

Authors:  Casey R Johnson; Samuel G Porter; Debra Coats; Kyly C Whitfield; Khin Mengkheang; Mark D Topazian; Philip R Fischer
Journal:  Glob Pediatr Health       Date:  2017-04-24

7.  Structure and gating mechanism of the transient receptor potential channel TRPV3.

Authors:  Appu K Singh; Luke L McGoldrick; Alexander I Sobolevsky
Journal:  Nat Struct Mol Biol       Date:  2018-08-20       Impact factor: 15.369

Review 8.  Polymodal roles of transient receptor potential channels in the control of ocular function.

Authors:  Peter S Reinach; Weiwei Chen; Stefan Mergler
Journal:  Eye Vis (Lond)       Date:  2015-03-02

Review 9.  Ocular transient receptor potential channel function in health and disease.

Authors:  Peter S Reinach; Stefan Mergler; Yuka Okada; Shizuya Saika
Journal:  BMC Ophthalmol       Date:  2015-12-17       Impact factor: 2.209

Review 10.  TRPV3 in Drug Development.

Authors:  Lisa M Broad; Adrian J Mogg; Elizabeth Eberle; Marcia Tolley; Dominic L Li; Kelly L Knopp
Journal:  Pharmaceuticals (Basel)       Date:  2016-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.